RE: SEC implicated in StockGate thanks for that concise post!
i have a suggestion - instead of worrying about all these rules, regulations, delisting requests, etc., why doesn't BT update investors with what onc is doing now, where they stand, and what they have planned near & intermediate term?
is it perhaps because a 6 patient ph II prostate trial doesn't cut much mustard with investors who prefer a little more substance to the cancer cure claims?
or maybe its a 2 year old application for FDA approval to
commence ph I/II glio trials in the US (and no apparent movement on nih) that investors are a bit antsy about?
or is it perhaps that BT has too often told people onc has plenty of cash just before he does another pp, that has turned off some larger buyers who might just be hanging around until BT decides to give them another opportunity to acquire shares at a big fat discount to market?
in the end the market is still a group of buyers & sellers coming together under the laws of supply & demand and i don't see a lot of buyers lining up to buy at these "bargain" prices, especially from all those very "knowledgeable" posters who were telling people not to sell at $10 or $11, since BT is the next Bill Gates.